medigraphic.com
Revista Médica Sinergia

2021, Número 01

<< Anterior Siguiente >>

Revista Médica Sinergia 2021; 6 (01)


Riesgo cardiovascular asociado a menopausia

Bolaños CBD, Ortega ME

Idioma: Español
Referencias bibliográficas: 15
Paginas: 1-12
Archivo PDF: 196.52 Kb.


RESUMEN

La enfermedad cardiovascular representa una de las principales causas de mortalidad en mujeres postmenopáusicas. Posterior a la menopausia, se presentan múltiples factores que aumentan el riesgo real de enfermedad cardiovascular, dentro de los cuales se incluye el tabaquismo, la hipertensión arterial, las dislipidemias, la diabetes mellitus tipo dos, la edad de la menarca y de la menopausia, así como los síntomas vasomotores, además de factores de riesgo tradicionales del periodo de transición, tales como la disminución de la tolerancia a la glucosa y la disfunción endotelial.Asimismo, se incluyen otros factores, como la disfunción ovárica primaria y la menopausia inducida quirúrgicamente, que suelen adelantar todos los procesos fisiológicos de una menopausia natural, resultando en un importante aumento del riesgo cardiovascular.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zhu D, Chung HF, Dobson AJ, Pandeya N, Giles GG, Bruinsma F, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health 2019; 4: e553– 64. https://doi.org/10.1016/S2468-2667(19)30155-0

  2. Muka T, Oliver-Williams C, Colpani V, Kunutsor S, Chowdhury S, et al. (2016) Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis. PLOS ONE 11(6): e0157417. https://doi.org/10.1371/journal.pone.0157417

  3. P. Collins, C. M. Webb, T. J. de Villiers, J. C. Stevenson, N. Panay & R. J. Baber (2016) Cardiovascular risk assessment in women – an update, Climacteric, 19:4, 329-336. https://doi.org/10.1080/13697137.2016.1198574

  4. Arteaga Urzúa E. Menopausia y riesgo cardiovascular. Rev Med Chil. 2016 Nov;144(11):1375-1376. http://dx.doi.org/10.4067/S0034-98872016001100001

  5. Bernhardt L, Lawson CA. Early menopause and risk of cardiovascular disease: an issue for young women. Lancet Public Health. 2019 Nov;4(11): e539-e540. https://doi.org/10.1016/ S2468-2667(19)30184-7

  6. Zhao D, Guallar E, Ouyang P, Subramanya V, Vaidya D, Ndumele CE, Lima JA, Allison MA, Shah SJ, Bertoni AG, Budoff MJ, Post WS, Michos ED. Endogenous Sex Hormones and Incident Cardiovascular Disease in Post- Menopausal Women. J Am Coll Cardiol. 2018 Jun 5;71(22):2555-2566. https://doi.org/10.1016/j.jacc.2018.01.083

  7. Fonseca, M.I.H., da Silva, I.T. & Ferreira, S.R.G. Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?. Diabetol Metab Syndr 9, 22 (2017). https://doi.org/10.1186/s13098-017-0221-5

  8. de Kat, A.C., Dam, V., Onland-Moret, N.C. et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med 15, 2 (2017). https://doi.org/10.1186/s12916-016-0762-8

  9. Honigberg MC, Zekavat SM, Aragam K, et al. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA. 2019;322(24):2411–2421. https://doi.org/10.1001/jama.2019.19191

  10. Biglia N, Cagnacci A, Gambacciani M, Lello S, Maffei S, Nappi RE. Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases? Climacteric. 2017 Aug;20(4):306-312. http://dx.doi.org/10.1080/13697137.2017.1315089

  11. Cagnacci A, Palma F, Romani C, Xholli A, Bellafronte M, Di Carlo C. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women?. Gynecological Endocrinology 2015; 31:5, 359- 362. https://doi.org/10.3109/09513590.2014.998188

  12. Franco OH, Muka T, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, Kavousi M. Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis. Maturitas 81 (2015) 353-361. http://dx.doi.org/10.1016/j.maturitas.2015.04.016

  13. Abbas SZ, Sangawan V, Das A, Pandey AK. Assessment of Cardiovascular Risk in Natural and Surgical Menopause. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):223-228. https://doi.org/10.4103/2230-8210.232384

  14. Naftolin F, Friedenthal J, Nachtigall R and Nachtigall L. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment. F1000Research 2019, 8(F1000 Faculty Rev):1576. https://doi.org/10.12688/f1000research.15548.1

  15. Boardman HMP, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews 2015, Issue 3. Art. No.: CD002229. https://doi.org/10.1002/14651858.CD002229.pub4




2020     |     www.medigraphic.com